Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Int J Occup Environ Health ; 12(3): 260-7, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16967834

RESUMEN

Atrazine is a common agricultural herbicide with endocrine disruptor activity. There is evidence that it interferes with reproduction and development, and may cause cancer. Although the U.S. Environmental Protection Agency (EPA) approved its continued use in October 2003, that same month the European Union (EU) announced a ban of atrazine because of ubiquitous and unpreventable water contamination. The authors reviewed regulatory procedures and government documents, and report efforts by the manufacturer of atrazine, Syngenta, to influence the U.S. atrazine assessment, by submitting flawed scientific data as evidence of no harm, and by meeting repeatedly and privately with EPA to negotiate the government's regulatory approach. Many of the details of these negotiations continue to be withheld from the public, despite EPA regulations and federal open-government laws that require such decisions to be made in the open.


Asunto(s)
Atrazina/efectos adversos , Industria Química/normas , Exposición a Riesgos Ambientales/prevención & control , Herbicidas/efectos adversos , Política Pública , United States Environmental Protection Agency/normas , Contaminación Química del Agua/efectos adversos , Atrazina/normas , Carcinógenos/farmacología , Carcinógenos/normas , Disruptores Endocrinos/farmacología , Disruptores Endocrinos/normas , Exposición a Riesgos Ambientales/normas , Unión Europea , Herbicidas/normas , Humanos , Negociación/métodos , Formulación de Políticas , Estados Unidos , Contaminación Química del Agua/legislación & jurisprudencia , Contaminación Química del Agua/prevención & control , Abastecimiento de Agua/legislación & jurisprudencia , Abastecimiento de Agua/normas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA